Suicidal Thoughts and Behavior With Antidepressant Treatment: A Reanalysis

By
-
0
333

In 2004 and 2006, the FDA concluded that SSRI antidepressants increased the risk of suicidal ideation in children and adolescents. However, in this month’s Archives of General Psychiatry, Robert Gibbons and four other researchers report that they have re-analyzed the data for Fluoxetine and Venlafaxine, and have concluded that, contrary to the FDA analysis, these two SSRIs do not increase the risk of suicidal behavior in children and adolescents. Three of the five researchers report having received funding from pharmaceutical companies. 
Read more                                              Discuss →

***

Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous articleLawsuit Filed for Alleged Zoloft-Related Birth Defects
Next articleCognitive Therapy Shown to be Effective For Schizophrenia
Kermit Cole
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].

LEAVE A REPLY